Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial
- 1 March 1999
- journal article
- clinical trial
- Published by Springer Nature in Gene Therapy
- Vol. 6 (3), 350-363
- https://doi.org/10.1038/sj.gt.3300833
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 24 references indexed in Scilit:
- Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFαGene Therapy, 1997
- Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus disseminationGene Therapy, 1997
- A Phase I Study of Adenovirus Mediated Gene Transfer of Interleukin 2 cDNA into Metastatic Breast Cancer or Melanoma. The Toronto Hospital, Toronto, Ontario, CanadaHuman Gene Therapy, 1997
- Adenovirus infection in cystic fibrosis patients: Implications for the use of adenoviral vectors for gene transferInfection, 1996
- Adenovirus-Based p53 Gene Therapy in Ovarian CancerGynecologic Oncology, 1995
- Evaluation of the Efficacy and Safety ofIn Vitro, Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNAHuman Gene Therapy, 1994
- Adenoviral Interleukin-2 Gene Transfer into P815 Tumor Cells Abrogates Tumorigenicity and Induces Antitumoral Immunity in MiceHuman Gene Therapy, 1993
- Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cellsCancer Immunology, Immunotherapy, 1993
- Induction of Antitumor Immunity by Interleukin-2 Gene-Transduced Mouse Mammary Tumor Cells Versus Transduced Mammary Stromal FibroblastsJNCI Journal of the National Cancer Institute, 1993
- Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cellsInternational Journal of Cancer, 1993